Engineered fluoride sensitivity enables biocontainment and selection of genetically-modified yeasts

Nat Commun. 2020 Oct 29;11(1):5459. doi: 10.1038/s41467-020-19271-1.

Abstract

Biocontainment systems are needed to neutralize genetically modified organisms (GMOs) that pose ecological threats outside of controlled environments. In contrast, benign selection markers complement GMOs with reduced fitness. Benign selection agents serve as alternatives to antibiotics, which are costly and risk spread of antibiotic resistance. Here, we present a yeast biocontainment strategy leveraging engineered fluoride sensitivity and DNA vectors enabling use of fluoride as a selection agent. The biocontainment system addresses the scarcity of platforms available for yeast despite their prevalent use in industry and academia. In the absence of fluoride, the biocontainment strain exhibits phenotypes nearly identical to those of the wildtype strain. Low fluoride concentrations severely inhibit biocontainment strain growth, which is restored upon introduction of fluoride-based vectors. The biocontainment strategy is stringent, easily implemented, and applicable to several eukaryotes. Further, the DNA vectors enable genetic engineering at reduced costs and eliminate risks of propagating antibiotic resistance.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Fluorides* / metabolism
  • Fluorides* / pharmacology
  • Genetic Engineering
  • Genetic Markers
  • Membrane Proteins / genetics*
  • Organisms, Genetically Modified / genetics*
  • Saccharomyces cerevisiae / drug effects
  • Saccharomyces cerevisiae / genetics*
  • Saccharomyces cerevisiae Proteins / genetics*
  • Selection, Genetic*
  • Synthetic Biology / methods

Substances

  • Fex1 protein, S cerevisiae
  • Genetic Markers
  • Membrane Proteins
  • Saccharomyces cerevisiae Proteins
  • Fluorides